In AD, glucose metabolism and glucose transporter-1 (GLUT1) function are impaired, leading to reduced glucose uptake with insulin resistance (IR) progression, which contributes to cognitive deficits (De la Monte 2017; Rubio et al. 2025). The gene discussed is INS; the disease is Alzheimer disease.